Abstract
Kidney transplant recipients (KTRs) are extremely vulnerable to SARS-CoV-2 infection and show an impaired immune response to SARS-CoV-2 vaccination. We analyzed factors related to vaccination efficiency in KTRs. In a multicenter prospective observational study (NCT04743947), IgG antibodies levels against SARS-CoV-2 spike S1 subunit and their neutralization capacity after SARS-CoV-2 vaccination were analyzed in 225 KTRs and compared to 176 controls. After the vaccination, 56 (24.9%) KTRs became seropositive of whom 68% had neutralizing antibodies. This immune response was significantly lower compared to controls (239 [78–519] BAU/ml versus 1826 [560–3180] BAU/ml for KTRs and controls, p
Cite
CITATION STYLE
Kantauskaite, M., Müller, L., Kolb, T., Fischer, S., Hillebrandt, J., Ivens, K., … Stegbauer, J. (2022). Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients. American Journal of Transplantation, 22(2), 634–639. https://doi.org/10.1111/ajt.16851
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.